Application 215577
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREGABALIN | PREGABALIN | TABLET, EXTENDED RELEASE;ORAL | 82.5MG | No | No |
| 002 | PREGABALIN | PREGABALIN | TABLET, EXTENDED RELEASE;ORAL | 165MG | No | No |
| 003 | PREGABALIN | PREGABALIN | TABLET, EXTENDED RELEASE;ORAL | 330MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215577-001 | PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | ||
| A215577-002 | PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | ||
| A215577-003 | PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215577-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215577-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215577-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-08-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-01-26 05:58 UTC | 2023-01 | A215577-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A215577-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A215577-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215577-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215577-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215577-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A215577-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A215577-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A215577-003 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A215577-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A215577-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A215577-003 | AB | 1 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3e9cfeb9-1e2b-ea79-e063-6394a90a67b1 | 2025-09-12 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals Inc. | e8e272a4-c181-4573-822b-2bb315b6ad37 | 2025-09-12 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| PREGABALIN | PREGABALIN | Cadila Pharmaceuticals Limited | 170c0c95-2ee8-4dff-bbd6-b87a21e8cf81 | 2025-09-12 | Warnings, Adverse reactions | PREGABALIN PREGABALIN |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | ceedde96-fdaf-4708-9ca1-e48e052cde75 | 2025-09-12 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals Inc. | a0da0534-b386-4c93-ae89-03b0e3325e02 | 2025-09-11 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 1760ccdc-46f7-4182-a563-96b13212cb7e | 2025-09-11 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 3dbfd868-8408-4514-ba1c-04a5d095c16a | 2025-09-10 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 31e7caf6-0a8b-f343-e063-6294a90ad729 | 2025-09-08 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| PREGABALIN | PREGABALIN | Rising Pharma Holdings, Inc. | dbebfa61-0685-41b4-8364-00b8d8b73714 | 2025-09-05 | Warnings, Adverse reactions | PREGABALIN PREGABALIN |
| Pregabalin | PREGABALIN | Novadoz Pharmaceuticals LLC | 193666f7-3c55-43b1-947a-2ffec40c687f | 2025-08-28 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| pregabalin | PREGABALIN | Indoco Remedies Limited | 0a8d9e35-46fd-4c70-bb7f-4e8b754f2794 | 2025-08-25 | Warnings, Adverse reactions | pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3c6daa12-5284-d9f1-e063-6294a90ae060 | 2025-08-15 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Alembic Pharmaceuticals Inc. | cf7b4b67-b017-47ac-af3f-bde5bd07bb0c | 2025-07-29 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab4efb3-1ae5-2504-e063-6294a90a6d1d | 2025-07-24 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab57054-02c2-5e28-e063-6294a90a71ab | 2025-07-24 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3a124f59-38c2-7280-e063-6394a90a43b4 | 2025-07-16 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3a1374f4-79dd-ebbc-e063-6394a90a53b0 | 2025-07-16 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | ef7c2e2c-c314-4bfd-a9fa-39f0b0884d34 | 2025-07-11 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | Amneal Pharmaceuticals NY LLC | 3099759f-cb24-40e8-b482-9388c38c73b9 | 2025-06-19 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
| Pregabalin | PREGABALIN | MARKSANS PHARMA LIMITED | b2b81bb6-5423-4221-8a61-f70a38d6a1e9 | 2025-06-10 | Warnings, Adverse reactions | Pregabalin PREGABALIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.